Gabriel Rosenfeld

Gabriel Rosenfeld

Auto-generated profile, based on publicly available information

Gabriel Rosenfeld

Office of Cyber Infrastructure and Computational Biology, National Institutes of Allergy and Infectious Diseases, 5601 Fishers Lane, Rockville, MD 20852, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GRGabriel Rosenfeld
Gabriel Rosenfeld
AGAndrei Gabrielian
Andrei Gabrielian
QWQinlu Wang
Qinlu Wang
JGJingwen Gu
Jingwen Gu
DHDarrell E. Hurt
Darrell E. Hurt
ARAlex Rosenthal
Alex Rosenthal
The TB Portals program provides a publicly accessible repository of TB case data containing multi-modal information such as case clinical characteristics, pathogen genomics, and radiomics. The real-world resource contains over 3400 TB cases, primarily drug resistant cases, and CT images with radiologist annotations are available for many of these cases. The breadth of data collected offers a patient-centric view into the etiology of the disease including the temporal context of the available imaging information. Here, we analyze a cohort of new TB cases with available radiologist observations of CTs taken around the time of initial registration of the case into the database and with available follow up to treatment outcome of cured or died. Follow up ranged from 5 weeks to a little over 2 years consistent with the longest treatment regimens for drug resistant TB and cases were registered within the years 2008 to 2019. The radiologist observations were incorporated into machine learning pipelines to test various class balancing strategies on the performance of predictive models. The modeling results support that the radiologist observations are predictive of treatment outcome. Moreover, inferential statistical analysis identifies markers of TB disease spread as having an association with poor treatment outcome including presence of radiologist observations in both lungs, swollen lymph nodes, multiple cavities, and large cavities. While the initial results are promising, further data collection is needed to incorporate methods to mitigate potential confounding such as including additional model covariates or matching cohorts on covariates of interest (e.g. demographics, BMI, comorbidity, TB subtype, etc.). Nonetheless, the preliminary results highlight the utility of the resource for hypothesis generation and exploration of potential biomarkers of TB disease severity and support these additional data collection efforts.

5 May 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
GRGabriel Rosenfeld
Gabriel Rosenfeld
AAAngelina Angelova
Angelina Angelova
CSChris Shin
Chris Shin
MQMariam Quinones
Mariam Quinones
DHDarrell Hurt
Darrell Hurt
While the biomedical community has embraced data sharing (e.g. results, raw data) and supported establishment of large research consortia (e.g. the Human Microbiome Project) aimed to standardize the quality of important sets of microbiome sequencing data, the reusability of most microbiome data is still limited by the quality of its associated metadata. To ensure that microbiome data is indeed FAIR (Findable, Accessible, Interoperable, and Reusable), it is necessary to consider tools and approaches that make it easier to provide high-quality metadata that is fit for purpose moving forward. Such tools and approaches could be informed by current efforts to harmonize and improve the quality of extant microbiome metadata.

27 September 2023 in European Journal of Radiology Open
Verified
Journal Article
Open access
GRGabriel Rosenfeld
Gabriel Rosenfeld
AGAndrei Gabrielian
Andrei Gabrielian
DHDarrell Hurt
Darrell Hurt
ARAlex Rosenthal
Alex Rosenthal
This study compares performance of Timika Score to standardized, detailed radiologist observations of Chest X rays (CXR) for predicting early infectiousness and subsequent treatment outcome in drug sensitive (DS) or multi-drug resistant (MDR) tuberculosis cases. It seeks improvement in prediction of these clinical events through these additional observations. This is a retrospective study analyzing cases from the NIH/NIAID supported TB Portals database, a large, trans-national, multi-site cohort of primarily drug-resistant tuberculosis patients. We analyzed patient records with sputum microscopy readings, radiologist annotated CXR, and treatment outcome including a matching step on important covariates of age, gender, HIV status, case definition, Body Mass Index (BMI), smoking, drug use, and Timika Score across resistance type for comparison. 2142 patients with tuberculosis infection (374 with poor outcome and 1768 with good treatment outcome) were retrospectively reviewed. Bayesian ANOVA demonstrates radiologist observations did not show greater predictive ability for baseline infectiousness (0.77 and 0.74 probability in DS and MDR respectively); however, the observations provided superior prediction of treatment outcome (0.84 and 0.63 probability in DS and MDR respectively). Estimated lung abnormal area and cavity were identified as important predictors underlying the Timika Score’s performance. Timika Score simplifies the usage of baseline CXR for prediction of early infectiousness of the case and shows comparable performance to using detailed, standardized radiologist observations. The score’s utility diminishes for treatment outcome prediction and is exceeded by the usage of the detailed observations although prediction performance on treatment outcome decreases especially in MDR TB cases.

17 September 2022 in medRxiv
Verified
Preprint
Open access
PDF file
QWQinlu Wang
Qinlu Wang
JGJingwen Gu
Jingwen Gu
AGAndrei Gabrielian
Andrei Gabrielian
GRGabriel Rosenfeld
Gabriel Rosenfeld
MQMariam Quiñones
Mariam Quiñones
ARAlex Rosenthal
Alex Rosenthal
BACKGROUND: Drug-resistant (DR) tuberculosis treatment is challenging and frequently leads to poor outcomes. An international collaboration, the National Institute of Allergy and Infectious Diseases (NIAID) TB Portals develops, maintains, and supports a multi-national database of tuberculosis cases, with an emphasis on drug-resistant tuberculosis. Patient records include clinical, radiological, genomic, and socioeconomic features. Establishing factors associated with unsuccessful treatment may help optimize treatment for the most challenging infections. METHODS: Association analysis and machine learning algorithms were applied to identify important factors associated with treatment outcome and predict the outcome for three patient cohorts, selected by drug resistance level representing 1575 patients in total. The predicted probabilities of poor treatment outcome from models were calibrated as a risk score ranging from 0 to 100 corresponding to confidence level of the model for treatment outcome. RESULTS: The features most associated with treatment success in all cohorts were body mass index (BMI), onset age, employment, education, smear-negative microscopy, and percent of abnormal volume in X-ray images, confirming previously reported findings, and identifying novel factors such as pathogen genomic markers. CONCLUSIONS: The identified features might help in establishing high-risk patients at the time of admission for tuberculosis treatment. This study integrates clinical, radiological, and pathogen genomics into a patient risk model, a way of determining risk through the application of machine learning on real-world data.

22 April 2022 in medRxiv
Verified
Preprint
Open access
PDF file
GRGabriel Rosenfeld
Gabriel Rosenfeld
AGAndrei Gabrielian
Andrei Gabrielian
AMAlyssa Meyer
Alyssa Meyer
ARAlex Rosenthal
Alex Rosenthal
The Tuberculosis (TB) Portals is an international program of 14 countries connecting clinical, genomic, and radiologist specialists to develop an openly available repository of deidentified TB cases with multi-modal data such as case clinical characteristics, pathogen genomics, and radiomics. This real-world data resource contains over 4000 TB cases, principally drug resistant cases, with over 4000 chest X-rays (CXR) images. The scope of curated data offers a case-focused perspective into the drivers of disease incorporating the chronological context of the presented CXR data. Here, we analyze a cohort consisting of new TB cases to understand the relationship between baseline sputum microscopy status and nearby Chest X rays images. The Timika score, a lung biomarker of disease severity, was derived for each CXR using available radiologist observations. The Timika score along with the radiologist observations were compared for predictive performance of baseline sputum microscopy status. Baseline sputum microscopy status is a useful marker of pre-treatment disease severity and infectiousness. The modeling results support that both the radiologist observations as well as Timika score are predictive of smear status and that Timika score performs similarly to the top 5 radiologist features by feature selection. Moreover, inferential statistical analysis identifies the factors having the greatest association with sputum smear positivity such as presence of radiologist observations in both lungs, presence of cavity, presence of nodule, and Timika score itself. The results are consistent with prior reports showing Timika Score utility for predicting baseline sputum smear and disease status. We report testing of Timika Score on the largest, openly available real-world dataset of TB cases that can serve as a reference to explore extant and new TB disease severity scores bridging radiological, microbiological, and clinical data. To illustrate, we visualize Timika score from images in our database with other cases characteristics demonstrating that this score captures lung biomarker status consistent with known clinical risk factors.

1 September 2017 in bioRxiv
Verified
Preprint
Open access
PDF file
GRGabriel Rosenfeld
Gabriel Rosenfeld
DLDawei Lin
Dawei Lin
While the impact of biomedical research has traditionally been measured using bibliographic metrics such as citation or journal impact factor, the data itself is an output which can be directly measured to provide additional context about a publication’s impact. Data are a resource that can be repurposed and reused providing dividends on the original investment used to support the primary work. Moreover, it is the cornerstone upon which a tested hypothesis is rejected or accepted and specific scientific conclusions are reached. Understanding how and where it is being produced enhances the transparency and reproducibility of the biomedical research enterprise. Most biomedical data are not directly deposited in data repositories and are instead found in the publication within figures or attachments making it hard to measure. We attempted to address this challenge by using recent advances in word embedding to identify the technical and methodological features of terms used in the free text of articles’ methods sections. We created term usage signatures for five types of biomedical research data, which were used in univariate clustering to correctly identify a large fraction of positive control articles and a set of manually annotated articles where generation of data types could be validated. The approach was then used to estimate the fraction of PLOS articles generating each biomedical data type over time. Out of all PLOS articles analyzed (n = 129,918), ~7%, 19%, 12%, 18%, and 6% generated flow cytometry, immunoassay, genomic microarray, microscopy, and high-throughput sequencing data. The estimate portends a vast amount of biomedical data being produced: in 2016, if other publishers generated a similar amount of data then roughly 40,000 NIH-funded research articles would produce ~56,000 datasets consisting of the five data types we analyzed. One Sentence Summary: Application of a word-embedding model trained on the methods sections of research articles allows for estimation of the production of diverse biomedical data types using text mining.